Moleculin Biotech, Inc.
5300 Memorial Drive, Suite 950
Houston, TX 77007
| June 17, 2025 |
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporate Finance
Washington, DC 20549
Attention: Daniel Crawford
|
Re: |
Moleculin Biotech, Inc. |
|
Registration Statement on Form S-1 |
|
Registration No. 333-287727 |
Ladies and Gentlemen:
Pursuant to Rule 461 of the Securities Act of 1933, as amended, Moleculin Biotech, Inc., a Delaware corporation (the “Company”), hereby respectfully requests that the effective date for the Registration Statement referred to above be accelerated so that it will be declared effective at 9:00 A.M. (Eastern Time) on June 18, 2025, or as soon thereafter as possible on such date.
|
|
Very truly yours,
Moleculin Biotech, Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
By: |
/s/ Jonathan P. Foster |
|
|
|
|
Name: Jonathan P. Foster |
|
|
|
|
Title: Chief Financial Officer |
|